A,B) Changes in CD19+ B cell frequency before and after the first... | Download Scientific Diagram
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome - ScienceDirect
RA | RITUXAN® (rituximab) Infusions & Dosing Schedule
Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders | PNAS
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study | BMC Musculoskeletal Disorders | Full Text
A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion.... | Download Scientific Diagram
a) Dot-blot analysis against rituximab (RTX) or bovine serum albumin... | Download Scientific Diagram
Clinical courses after RTX infusion in children with refractory NS | Download Table
Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
First Infusion RTX 4000 Series Official Trailer - YouTube
Patient characteristics At the time of RTX infusion | Download Table
Baseline characteristics at first RTX infusion in all MS, RRMS and PMS... | Download Table
Comparison of Switching from the Originator Rituximab to the Biosimilar Rituximab GP2013 or Re‑Treatment with the Originator Rituximab in Patients with Active Rheumatoid Arthritis: Safety and Immunogenicity Results from a Multicenter, Randomized,
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Clinical and laboratory parameters after RTX infusion | Download Scientific Diagram
A, ECG prior to RTX infusion. B, Occurrence of PVC during RTX infusion.... | Download Scientific Diagram
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar | SpringerLink
CD20 before and after infusion of RTX. The '3rd day', '2nd week', '1st... | Download Scientific Diagram
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland | PLOS ONE
Patient characteristics At the time of RTX infusion | Download Table
Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders | PNAS
RA | RITUXAN® (rituximab) Infusion Steps & Resources
